MARCO and neoplasm: Separate models (melanoma) have found that the injection of anti-MARCO antibodies into tumor-bearing mice leads to an influx of NK cells and CD8+ T cells, and this effect is augmented by the addition of anti-PD-L1 antibodies [421].